Yurpeak 12.5 mg Kwikpen

Yurpeak 12.5mg Kwikpen contains Tirzepatide, a dual GIP and GLP-1 receptor agonist used for type 2 diabetes management. It is taken once a week and helps with weight loss and blood sugar control.

Brand Name: Yurpeak

Composition: Tirzepatide

Mechanism of Action:

Tirzepatide is a dual GIP and GLP-1 receptor agonist that helps control blood sugar levels in people with type 2 diabetes. It works by slowing gastric emptying, which can increase feelings of fullness and may support weight loss. It aslo reduce glucagon secretion and enhances insulin production in response to food intake, helping to lowers sugar levels.

Uses:

·               Type-2 Diabetes Mellitus

·               Weight Management

Dosage and Administration:

Given once a week as a subcutaneous injection. Depending on tolerance and individual response, the dosage may be changed.

Side Effects:

·               Nausea

·               Vomiting

·               Diarrhea

·               Constipation

·               Decreased appetite

·               Injection site reactions (Itching, Rashes)

·               Hypoglycemia

Safety Advise:

Lungs  

The safety of Yurpeak for individuals with lung issues is uncertain. Kindly speak with your healthcare provider.

Liver  

The safety of Yurpeak for individuals with liver issues is uncertain. Kindly speak with your healthcare provider.

Kidney  

The safety of Yurpeak for individuals with Kidney issues is uncertain. Kindly speak with your healthcare provider.

Pregnancy  

Yurpeak should be used during pregnancy only if clearly needed, Kindly speak with your healthcare provider.

Breast Feeding  

Using Yurpeak while nursing is most likely dangerous. Kindly speak with your healthcare provider. 

Storage:

Store Yurpeak 12.5mg Injection in a refrigerator (2°C to 8°C), do not freeze up, protect from sunlight, and use within 21 days if kept at room temperature (up to 30°C).

How to use this Medication?

This drug is administered subcutaneously. You'll learn how to prepare and administer it. It is administered once every seven days, or once a week. Unless instructed otherwise by your healthcare provider, continue taking it.

You should inject this medication and insulin separately if you take both together. Don't combine them. Avoid administering the shots directly close to one another. With every injection, rotate the injection sites.

References:

1.   Baker DE, Walley K, Levien TL. Tirzepatide. Hospital Pharmacy. 2023 Jun;58(3):227-43.

2.   Karagiannis T, Avgerinos I, Liakos A, Del Prato S, Matthews DR, Tsapas A, Bekiari E.Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis. Diabetologia. 2022 Aug;65(8):1251-61.

3.   Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022 Jul 21;387(3):205-16.

4.   Chavda VP, Ajabiya J, Teli D, Bojarska J, Apostolopoulos V. Tirzepatide, a new era of dual-targeted treatment for diabetes and obesity: a mini-review. Molecules. 2022 Jul 5;27(13):4315.

Disclaimer:

The main goal of Apothecare Specialities Pvt Ltd is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Specialities Pvt Ltd, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name:  Cipla LTD
Address:  Cipla House, Peninsula Business Park, Ganpatrao Kadam marg, Lower Parel, Mumbai 400013
Country of origin: Italy

Frequently Asked Questions:

1. What is Yurpeak 12.5mg Kwikpen used for?

Yurpeak 12.5mg Injection (Tirzepatide) is prescribed for the management of Type 2 diabetes and may help control blood sugar levels. It may also be associated with weight reduction in some patients by reducing appetite and slowing digestion. However, individual outcomes may vary, and it should only be used as directed by your doctor.

2. How does Yurpeak (Tirzepatide) work?

Yurpeak is a dual GIP and GLP-1 receptor agonist. It is believed to work by:

•         Stimulating insulin secretion in a glucose-dependent manner

•         Potentially reducing blood sugar levels

•         Slowing gastric emptying in some patients

•         May help reduce hunger and calorie intake

The exact magnitude of these effects may vary between individuals.

3. How should Yurpeak 12.5mg Kwikpen be taken?

Yurpeak is intended to be administered as a subcutaneous injection once weekly (under the skin). It is generally recommended to be taken on the same day each week, as prescribed by your doctor. Do not alter the schedule without medical guidance.

4. What is the recommended dosage of Yurpeak?

Treatment typically begins at 12.5mg once weekly and may be gradually increased to 15mg, depending on the patient's response and tolerability. Dose adjustments should only be made under the supervision of a qualified healthcare professional.

5. What are the possible side effects of Yurpeak?

Some patients may experience side effects such as:

•         Nausea

•         Diarrhoea

•         Vomiting

•         Constipation

•         Reduced appetite

These are generally reported as mild and may improve over time. Not all patients will experience these effects. Consult your doctor if side effects persist or worsen.

6. Are there any serious side effects to be aware of?

Although uncommon, some patients may experience more serious side effects, which may include:

•         Pancreatitis

•         Kidney-related complications

•         Gallbladder issues

•         Severe allergic reactions

Please consult your doctor immediately if you notice any severe or unusual symptoms. This list may not be exhaustive.

7. Can Yurpeak help with weight loss?

Some clinical studies have suggested that Yurpeak may be associated with weight reduction in certain patients, potentially through appetite suppression and reduced calorie intake. However, weight loss is not guaranteed and may vary significantly between individuals. It is not approved solely as a weight-loss drug in all regions. Please consult your physician to understand whether this benefit may apply to your situation.

8. Who should not use Yurpeak?

Yurpeak may not be suitable for certain patients, including those with:

•         A history of pancreatitis

•         Severe gastrointestinal disorders

•         Known hypersensitivity or allergy to Tirzepatide

This is not a complete list of contraindications. Always consult your doctor before starting treatment to assess your individual suitability.

9. Can Yurpeak be taken with other diabetes medicines?

Yurpeak may be used alongside certain other antidiabetic medications, but caution is advised when combining it with insulin or insulin secretagogues, as this may increase the risk of low blood sugar (hypoglycaemia) in some patients. Your doctor will assess the most appropriate combination for your condition.

10. Is Yurpeak `12.5mg Kwikpen safe for long-term use?

Long-term safety data for Yurpeak is still being gathered. It may be used over an extended period under appropriate medical supervision, with regular monitoring to assess its continued safety and effectiveness in individual patients.

11. How should Yurpeak be stored?

Yurpeak should generally be stored in a refrigerator at 2°C–8°C. It should not be frozen and must be kept away from direct light. Always follow the storage instructions on the product label or as advised by your pharmacist.

12. Is Yurpeak available without a prescription in India?

No. Yurpeak is a prescription-only medicine and must be obtained and used only under the guidance of a qualified and licensed healthcare professional.

Medical Disclaimer:

Yurpeak 12.5mg Kwikpen is a prescription-only medicine and must be used strictly under the supervision and guidance of a qualified healthcare professional. Do not self-medicate, alter the dosage, or discontinue use without consulting your doctor. The information provided here is for educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Individual results, benefits, and risks may vary. Always consult your physician before starting, changing, or stopping any medication.